닥플 플러스
2nd Samsung Medical Center Thoracic Oncology Symposium - Lung Cancer
삼성서울병원
연수평점 :6점
오프라인
주관
삼성서울병원 / 심장혈관흉부외과
교육일자
2026-11-28
수강료
50,000원
교육형태
오프라인
등록일시
2026-09-09
교육시간
6시간 50분
연수평점
6점
장소
서울특별시 삼성서울병원 본관 B1 대강당
교육종류
흉부외과, 의사학
타임테이블
| 날짜 | 시간 | 강의명 | 강사 | 구분 |
|---|---|---|---|---|
| 2026-11-28 | 08:40~08:45 | Opening remark | 김홍관(삼성서울병원 심장혈관흉부외과) | - |
| 2026-11-28 | 08:45~08:50 | Welcome Address | 김희철(삼성서울병원 대장항문외과) | - |
| 2026-11-28 | 08:50~09:10 | STAS: Evolution of Concept and Frozen Section Reliability | 정진행(분당서울대병원 병리과) | - |
| 2026-11-28 | 09:10~09:30 | Preoperative Radiological Prediction of STAS | 김태정(삼성서울병원 영상의학과) | - |
| 2026-11-28 | 09:30~09:50 | The Intraoperative Dilemma — When Should Suspected STAS Prompt Conversion to Lobectomy | 이창영(세브란스병원 심장혈관흉부외과) | - |
| 2026-11-28 | 09:50~10:00 | Discussion and Q&A | - | - |
| 2026-11-28 | 10:00~10:15 | Coffee break | - | - |
| 2026-11-28 | 10:15~10:35 | Optimal Margin during Sublobar Resection: Current Guidelines and Evidence (Oncologic Background) | 조석기(분당서울대병원 심장혈관흉부외과) | - |
| 2026-11-28 | 10:35~10:55 | Margin Planning in Segmentectomy and Wedge Resection: Technical Aspect | 유우식(아주대병원 심장혈관흉부외과) | - |
| 2026-11-28 | 10:55~11:15 | Pathologic Consideration: Resection Margin & Intrapulmonary Lymph Node Assessment | 김세희(삼성서울병원 병리과) | - |
| 2026-11-28 | 11:15~11:35 | Locoregional Recurrence and Surveillance after Sublobar Resection | 이근동(서울아산병원 심장혈관흉부외과) | - |
| 2026-11-28 | 11:35~11:45 | Discussion and Q&A | - | - |
| 2026-11-28 | 11:45~12:10 | Challenging Cases in the Operating Room after Neoadjuvant Chemoimmunotherapy: Lessons and Solutions | Mir Alireza Hoda(Medical University of Vienna Austria) | - |
| 2026-11-28 | 12:10~12:35 | Clinical Challenges in Neoadjuvant Chemoimmunotherapy: How to Manage Poor Responders, Toxicity, and Progression | Daniel Tan(National Cancer Centre Singapore) | - |
| 2026-11-28 | 12:35~13:35 | Lunch break | - | - |
| 2026-11-28 | 13:35~13:55 | Resectable N0/N1 NSCLC: Can Neoadjuvant Chemoimmunotherapy Move Down? | 이정희(삼성서울병원 심장혈관흉부외과) | - |
| 2026-11-28 | 13:55~14:15 | Expanding the Boundary in Borderline Resectable NSCLC: Before and After Neoadjuvant Chemoimmunotherapy | Mir Alireza Hoda(Medical University of Vienna Austria) | - |
| 2026-11-28 | 14:15~14:35 | Resectable NSCLC with Unfavorable IO Biomarkers: Immunotherapy or Targeted Therapy? | Daniel Tan(National Cancer Centre Singapore) | - |
| 2026-11-28 | 14:35~14:45 | Discussion and Q&A | - | - |
| 2026-11-28 | 14:45~15:05 | Coffee break | - | - |
| 2026-11-28 | 15:05~15:25 | Pulmonary Complications after Neoadjuvant Chemoimmunotherapy | 유홍석(삼성서울병원 호흡기내과) | - |
| 2026-11-28 | 15:25~15:45 | Does Response Reshape the Operation after Neoadjuvant Chemoimmunotherapy? | 이호연(삼성서울병원 영상의학과) | - |
| 2026-11-28 | 15:45~16:05 | Tailoring Adjuvant Therapy after Neoadjuvant Chemoimmunotherapy | 이세훈(삼성서울병원 혈액종양내과) | - |
| 2026-11-28 | 16:05~16:15 | Discussion and Q&A | - | - |
| 2026-11-28 | 16:15~16:35 | Coffee break | - | - |
| 2026-11-28 | 16:35~17:35 | Panel | - | - |
| 2026-11-28 | 17:35~17:45 | Closing Remarks | - | - |
비고
사전등록 : 30,000원 현장등록 : 50,000원
문의처
담당자
김희주
연락처
02-3410-3488
이메일
heejoo90.kim@samsung.com